Guidance for Modifying the Definition of Diseases
- 1 July 2017
- journal article
- review article
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 177 (7) , 1020-1025
Abstract
Importance No guidelines exist currently for guideline panels and others considering changes to disease definitions. Panels frequently widen disease definitions, increasing the proportion of the population labeled as unwell and potentially causing harm to patients. We set out to develop a checklist of issues, with guidance, for panels to consider prior to modifying a disease definition. Observations We assembled a multidisciplinary, multicontinent working group of 13 members, including members from the Guidelines International Network, Grading of Recommendations Assessment, Development and Evaluation working group, and the World Health Organisation. We used a 5-step process to develop the checklist: (1) a literature review of issues, (2) a draft outline document, (3) a Delphi process of feedback on the list of issues, (4) a 1-day face-to-face meeting, and (5) further refinement of the checklist. The literature review identified 12 potential issues. From these, the group developed an 8-item checklist that consisted of definition changes, number of people affected, trigger, prognostic ability, disease definition precision and accuracy, potential benefits, potential harms, and the balance between potential harms and benefits. The checklist is accompanied by an explanation of each item and the types of evidence to assess each one. We used a panel’s recent consideration of a proposed change in the definition of gestational diabetes mellitus (GDM) to illustrate use of the checklist. Conclusions and Relevance We propose that the checklist be piloted and validated by groups developing new guidelines. We anticipate that the use of the checklist will be a first step to guidance and better documentation of definition changes prior to introducing modified disease definitions.Keywords
This publication has 35 references indexed in Scilit:
- The challenge of overdiagnosis begins with its definitionBMJ, 2015
- Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient dataThe Lancet, 2014
- Prevalence of the Polycystic Ovary Syndrome in Female Residents of Chengdu, ChinaGynecologic and Obstetric Investigation, 2014
- Prevalence and Control of Diabetes in Chinese AdultsJAMA, 2013
- Expanding Disease Definitions in Guidelines and Expert Panel Ties to Industry: A Cross-sectional Study of Common Conditions in the United StatesPLOS Medicine, 2013
- The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trialsThe Lancet, 2012
- Preventing overdiagnosis: how to stop harming the healthyBMJ, 2012
- Estimates of the Proportion of Older White Women Who Would Be Recommended for Pharmacologic Treatment by the New U.S. National Osteoporosis Foundation GuidelinesJournal of Bone and Mineral Research, 2009
- Redefinition of Myocardial Infarction: Prospective Evaluation in the CommunityYearbook of Cardiology, 2007
- An evidence based approach to individualising treatmentBMJ, 1995